REG - Nexteq PLC - Transaction in Own Shares and Total Voting Rights

NexteqAnnouncement

12/03/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260312:nRSL2930Wa&default-theme=true

RNS Number : 2930W  Nexteq PLC  12 March 2026

12 March 2026

Nexteq plc

("Nexteq" or the "Group")

 

Transaction in Own Shares

and

Total Voting Rights

 

Nexteq PLC (the "Company") announces that on 11 March 2026 it purchased 73,825
ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a
price of 74.50 pence each, to be held in treasury.

Further to the above transaction, the Company advises that its issued share
capital stands at 66,539,060 Ordinary Shares, with 9,865,631 Ordinary Shares
held in treasury. Consequently, the total voting rights of the Company is
56,673,429.

The above voting rights figure of 56,673,429 may be used by shareholders as
the denominator for the calculations by which they determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries

 Nexteq PLC

 Duncan Faithfull, Chief Executive Officer        Telephone: +44 (0)1223 892 696

 Matt Staight, Chief Financial Officer

 Nominated Adviser and Broker:

 Cavendish Capital Markets Ltd                    Telephone: +44 (0) 20 7220 0500

 Matt Goode / Edward Whiley (Corporate Finance)

 Harriet Ward (ECM)

 Financial PR:

 Alma Strategic Communications                    Telephone: +44 (0)20 3405 0205

 Hilary Buchanan/ Emma Thompson

 

Aggregate information:

 Venue  Volume-weighted average price (pence per share)  Aggregated volume
 AIMX   74.50                                            73,825

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSEAXDFFELKEFA



            Copyright 2019 Regulatory News Service, all rights reserved